Related Experiment Videos
Summary
Older adults aged 65+ with end-stage renal failure (ESRF) benefit from regular hemodialysis treatment (RHDT). This study found similar outcomes compared to younger patients, recommending RHDT inclusion for elderly ESRF individuals.
Area of Science:
- Nephrology
- Geriatric Medicine
- Internal Medicine
Background:
- End-stage renal failure (ESRF) affects a growing elderly population.
- The efficacy and safety of regular hemodialysis treatment (RHDT) in older adults require further investigation.
Purpose of the Study:
- To compare the outcomes of RHDT in elderly patients (65+) versus younger adults (40-55).
- To evaluate the impact of RHDT on mortality, morbidity, and various clinical parameters in different age groups.
Main Methods:
- Retrospective study comparing two groups of 26 patients each undergoing RHDT.
- Analysis of parameters including mortality, morbidity, cardiovascular status, vascular access, anemia, and neurological disorders.
Main Results:
- No significant differences in most parameters between the elderly (65+) and younger (40-55) RHDT groups.
- A slightly higher morbidity rate was observed in the older patient cohort.
Conclusions:
- Elderly patients (65+) with ESRF demonstrate comparable outcomes to younger patients on RHDT.
- The study recommends the inclusion of older patients in RHDT programs, supporting age-inclusive renal replacement therapy.